Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection. 2020

Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
Department of Orthopaedic Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

OBJECTIVE To report on our clinical outcomes and on the experience of managing acute periprosthetic joint infection (PJI) with debridement, antibiotics, and implant retention (DAIR). METHODS We performed a retrospective review of all patients who were diagnosed with acute PJI after primary hip or knee replacement surgeries and who were managed with DAIR in our prospective joint replacement registry from 2008 to 2019. The diagnosis of PJI was made according to the 2011 Musculoskeletal Infection Society (MSIS) criteria. The symptom onset duration, inflammatory marker levels (i.e. C-reactive protein [CRP], erythrocyte sedimentation rate [ESR], white cell count [WBC], and synovial WBC count), functional scores including the Knee Society Score (KSS), the KSS functional score and the Harris Hip Score (HHS), bacteriology, and surgical outcomes of the patients were tracked and recorded. A paired sample of joint fluid and tissues was also sent for a metagenomic next-generation sequencing (mNGS) test. A paired-samples t-test was used to compare the differences in the inflammatory markers and functional scores before and after surgery. RESULTS A total of 24 patients with 7 infections after hip replacements and 17 infections after knee replacements were included. A total of 21 patients exhibited early postoperative infections, and 3 exhibited late acute hematogenous infections. During a mean follow-up time of 29.2 ± 15.1 months, 22 patients were successfully treated, whereas 2 patients were unsuccessfully treated and required repeated DAIR. The overall success rate of DAIR was 91.7%. For staphylococcal infections, DAIR had a 100% success rate. Five patients who presented with symptoms between 4 and 8 weeks also achieved a 100% success rate. At the last follow-up, the mean CRP level decreased from 52.6 ± 34.0 to 5.4 ± 3.5 (P < 0.001), and the mean ESR level decreased from 72.3 ± 34.3 to 20.2 ± 12.1 (P < 0.001). The mean KSS score increased from 44.8 ± 12.2 to 81.4 ± 9.2 (P < 0.001), and the mean KSS functional score increased from 38.1 ± 3.5 to 73.9 ± 23.0 (P < 0.001), and the mean HHS score increased from 34.4 ± 6.9 to 84.1 ± 15.1 (P < 0.001). The overall pathogen identification rate was 91.7% (22/24 cases). The success rates for Staphylococcus, Streptococcus, and the other pathogens were 100% (9/9 cases), 71.4% (5/7 cases), and 100% (6/6 cases), respectively. CONCLUSIONS Debridement, antibiotics, and implant retention has a high success rate for the treatment of acute PJI and may be performed in selected patients whose symptoms have been sustained for over 4 weeks. A high rate of success for staphylococcal infections was reported with the use of DAIR.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003646 Debridement The removal of foreign material and devitalized or contaminated tissue from or adjacent to a traumatic or infected lesion until surrounding healthy tissue is exposed. (Dorland, 27th ed) Debridements
D004185 Disability Evaluation Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits. Disability Evaluations,Evaluation, Disability,Evaluations, Disability
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
January 2016, Hip international : the journal of clinical and experimental research on hip pathology and therapy,
Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
January 2021, Journal of surgical orthopaedic advances,
Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
January 2020, Journal of bone and joint infection,
Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
October 2021, The Journal of arthroplasty,
Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
January 2020, JB & JS open access,
Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
July 2017, Hip international : the journal of clinical and experimental research on hip pathology and therapy,
Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
June 2021, The bone & joint journal,
Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
December 2020, The Journal of arthroplasty,
Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
February 2023, The Journal of arthroplasty,
Chao-Fan Zhang, and Long He, and Xin-Yu Fang, and Zi-da Huang, and Guo-Chang Bai, and Wen-Bo Li, and Wen-Ming Zhang
May 2024, Open forum infectious diseases,
Copied contents to your clipboard!